US Bancorp’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $119M | Sell |
856,921
-2,150
| -0.3% | -$301K | 0.15% | 116 |
|
|
2025
Q4 | $105M | Buy |
859,071
+9,187
| +1% | +$1.12M | 0.12% | 129 |
|
|
2025
Q3 | $94.3M | Sell |
849,884
-4,668
| -0.5% | -$531K | 0.11% | 136 |
|
|
2025
Q2 | $94.7M | Sell |
854,552
-22,670
| -3% | -$2.41M | 0.12% | 135 |
|
|
2025
Q1 | $98.3M | Sell |
877,222
-218,098
| -20% | -$22.5M | 0.13% | 127 |
|
|
2024
Q4 | $101M | Sell |
1,095,320
-27,216
| -2% | -$2.45M | 0.13% | 129 |
|
|
2024
Q3 | $94.1M | Sell |
1,122,536
-70,772
| -6% | -$5.4M | 0.12% | 135 |
|
|
2024
Q2 | $81.9M | Sell |
1,193,308
-194,668
| -14% | -$13M | 0.11% | 136 |
|
|
2024
Q1 | $102M | Sell |
1,387,976
-31,356
| -2% | -$2.41M | 0.14% | 124 |
|
|
2023
Q4 | $115M | Sell |
1,419,332
-36,531
| -3% | -$2.84M | 0.17% | 107 |
|
|
2023
Q3 | $110M | Sell |
1,455,863
-30,111
| -2% | -$2.32M | 0.18% | 106 |
|
|
2023
Q2 | $115M | Sell |
1,485,974
-74,881
| -5% | -$5.97M | 0.18% | 105 |
|
|
2023
Q1 | $130M | Sell |
1,560,855
-110,046
| -7% | -$9.11M | 0.22% | 97 |
|
|
2022
Q4 | $143M | Buy |
1,670,901
+109,507
| +7% | +$8.67M | 0.25% | 82 |
|
|
2022
Q3 | $96.3M | Buy |
1,561,394
+4,761
| +0.3% | +$300K | 0.2% | 102 |
|
|
2022
Q2 | $96.2M | Sell |
1,556,633
-30,551
| -2% | -$1.89M | 0.19% | 111 |
|
|
2022
Q1 | $94.4M | Sell |
1,587,184
-61,353
| -4% | -$3.92M | 0.16% | 118 |
|
|
2021
Q4 | $120M | Buy |
1,648,537
+1,499
| +0.1% | +$103K | 0.19% | 106 |
|
|
2021
Q3 | $115M | Buy |
1,647,038
+47,456
| +3% | +$3.33M | 0.22% | 100 |
|
|
2021
Q2 | $110M | Buy |
1,599,582
+38,191
| +2% | +$2.55M | 0.21% | 102 |
|
|
2021
Q1 | $101M | Buy |
1,561,391
+117,679
| +8% | +$7.59M | 0.2% | 102 |
|
|
2020
Q4 | $84.1M | Buy |
1,443,712
+84,815
| +6% | +$5.12M | 0.18% | 114 |
|
|
2020
Q3 | $85.9M | Sell |
1,358,897
-57,785
| -4% | -$4.01M | 0.21% | 101 |
|
|
2020
Q2 | $109M | Sell |
1,416,682
-19,837
| -1% | -$1.52M | 0.29% | 79 |
|
|
2020
Q1 | $107M | Buy |
1,436,519
+181,229
| +14% | +$12.5M | 0.34% | 72 |
|
|
2019
Q4 | $81.6M | Buy |
1,255,290
+12,388
| +1% | +$807K | 0.21% | 103 |
|
|
2019
Q3 | $78.8M | Buy |
1,242,902
+91,724
| +8% | +$6M | 0.21% | 104 |
|
|
2019
Q2 | $77.8M | Buy |
1,151,178
+81,548
| +8% | +$5.36M | 0.22% | 104 |
|
|
2019
Q1 | $69.5M | Buy |
1,069,630
+10,665
| +1% | +$709K | 0.2% | 109 |
|
|
2018
Q4 | $66.2M | Sell |
1,058,965
-34,735
| -3% | -$2.43M | 0.21% | 104 |
|
|
2018
Q3 | $84.4M | Sell |
1,093,700
-57,363
| -5% | -$4.33M | 0.24% | 99 |
|
|
2018
Q2 | $81.5M | Sell |
1,151,063
-20,009
| -2% | -$1.41M | 0.25% | 94 |
|
|
2018
Q1 | $88.3M | Buy |
1,171,072
+52,618
| +5% | +$4.18M | 0.27% | 93 |
|
|
2017
Q4 | $80.1M | Buy |
1,118,454
+33,981
| +3% | +$2.58M | 0.25% | 100 |
|
|
2017
Q3 | $87.9M | Buy |
1,084,473
+62,434
| +6% | +$4.77M | 0.28% | 87 |
|
|
2017
Q2 | $72.3M | Buy |
1,022,039
+144,403
| +16% | +$9.61M | 0.24% | 99 |
|
|
2017
Q1 | $59.6M | Sell |
877,636
-46,768
| -5% | -$3.29M | 0.2% | 106 |
|
|
2016
Q4 | $66.2M | Sell |
924,404
-50,424
| -5% | -$3.75M | 0.24% | 100 |
|
|
2016
Q3 | $77.1M | Sell |
974,828
-40,927
| -4% | -$3.32M | 0.29% | 88 |
|
|
2016
Q2 | $84.7M | Sell |
1,015,755
-21,093
| -2% | -$1.87M | 0.32% | 80 |
|
|
2016
Q1 | $95.2M | Sell |
1,036,848
-33,705
| -3% | -$3.04M | 0.37% | 72 |
|
|
2015
Q4 | $108M | Sell |
1,070,553
-17,073
| -2% | -$1.78M | 0.44% | 55 |
|
|
2015
Q3 | $107M | Sell |
1,087,626
-7,636
| -0.7% | -$848K | 0.45% | 56 |
|
|
2015
Q2 | $128M | Sell |
1,095,262
-13,917
| -1% | -$1.52M | 0.5% | 47 |
|
|
2015
Q1 | $109M | Buy |
1,109,179
+46,423
| +4% | +$4.71M | 0.42% | 57 |
|
|
2014
Q4 | $100M | Buy |
1,062,756
+25,367
| +2% | +$2.62M | 0.39% | 59 |
|
|
2014
Q3 | $110M | Buy |
1,037,389
+9,906
| +1% | +$970K | 0.45% | 53 |
|
|
2014
Q2 | $85.2M | Buy |
1,027,483
+59,044
| +6% | +$4.6M | 0.34% | 60 |
|
|
2014
Q1 | $68.6M | Buy |
968,439
+66,004
| +7% | +$5.18M | 0.28% | 75 |
|
|
2013
Q4 | $67.8M | Sell |
902,435
-10,587
| -1% | -$737K | 0.27% | 78 |
|
|
2013
Q3 | $57.4M | Buy |
913,022
+59,256
| +7% | +$3.54M | 0.25% | 87 |
|
|
2013
Q2 | $43.8M | Buy |
+853,766
| New | +$44.5M | 0.2% | 104 |
|
Other funds holding GILD
VCM
VPM
US Bancorp's GILD Position: Q1 2026 in Review
US Bancorp reduced its Gilead Sciences (GILD) stake by 0.25% in Q1 2026, selling an estimated $301K and leaving 856,921 shares worth $119M. The position accounts for 0.15% of the portfolio, ranked #116.
US Bancorp first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $143M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- US Bancorp held 856,921 shares of Gilead Sciences worth $119M as of Q1 2026.
- US Bancorp sold 2,150 Gilead Sciences shares in Q1 2026, an estimated $301K.
- Gilead Sciences made up 0.15% of US Bancorp's portfolio in Q1 2026, its #116 holding.
- US Bancorp first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- US Bancorp's Gilead Sciences position peaked at $143M in Q4 2022.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.